Perdagangan BIOLASE - BIOL CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.14 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.024068% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | 0.001846% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | 4.54 |
Open* | 4.38 |
1-Year Change* | 1.62% |
Day's Range* | 4.26 - 4.58 |
52 wk Range | 0.35-9.58 |
Average Volume (10 days) | 229.89K |
Average Volume (3 months) | 11.78M |
Market Cap | 12.50M |
P/E Ratio | -100.00K |
Shares Outstanding | 35.58M |
Revenue | 46.82M |
EPS | -3.68 |
Dividend (Yield %) | N/A |
Beta | 1.44 |
Next Earnings Date | Mar 28, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jun 29, 2022 | 4.30 | -0.08 | -1.83% | 4.38 | 4.58 | 4.22 |
Jun 28, 2022 | 4.54 | 0.32 | 7.58% | 4.22 | 5.00 | 4.22 |
Jun 27, 2022 | 5.08 | 0.86 | 20.38% | 4.22 | 5.19 | 4.22 |
Jun 24, 2022 | 4.47 | 0.25 | 5.92% | 4.22 | 4.60 | 4.22 |
Jun 23, 2022 | 4.19 | 0.12 | 2.95% | 4.07 | 4.30 | 4.07 |
Jun 22, 2022 | 4.05 | -0.27 | -6.25% | 4.32 | 4.52 | 3.99 |
Jun 21, 2022 | 4.32 | 0.04 | 0.93% | 4.28 | 4.53 | 4.16 |
Jun 17, 2022 | 4.51 | 0.22 | 5.13% | 4.29 | 4.51 | 4.29 |
Jun 16, 2022 | 4.17 | -0.01 | -0.24% | 4.18 | 4.37 | 4.16 |
Jun 15, 2022 | 4.26 | 0.19 | 4.67% | 4.07 | 4.26 | 4.07 |
Jun 14, 2022 | 4.26 | 0.17 | 4.16% | 4.09 | 4.37 | 4.09 |
Jun 13, 2022 | 4.10 | -0.17 | -3.98% | 4.27 | 4.34 | 4.07 |
Jun 10, 2022 | 4.56 | -0.06 | -1.30% | 4.62 | 4.62 | 4.47 |
Jun 9, 2022 | 4.67 | 0.03 | 0.65% | 4.64 | 4.76 | 4.64 |
Jun 8, 2022 | 4.63 | 0.01 | 0.22% | 4.62 | 4.71 | 4.59 |
Jun 7, 2022 | 4.64 | 0.02 | 0.43% | 4.62 | 4.73 | 4.62 |
Jun 6, 2022 | 4.67 | 0.03 | 0.65% | 4.64 | 4.79 | 4.59 |
Jun 3, 2022 | 4.82 | 0.20 | 4.33% | 4.62 | 4.90 | 4.62 |
Jun 2, 2022 | 4.67 | 0.04 | 0.86% | 4.63 | 4.80 | 4.61 |
Jun 1, 2022 | 4.63 | -0.15 | -3.14% | 4.78 | 4.78 | 4.57 |
BIOLASE Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 51.81 | 46.926 | 46.155 | 37.799 | 22.78 | 39.188 |
Revenue | 51.81 | 46.926 | 46.155 | 37.799 | 22.78 | 39.188 |
Cost of Revenue, Total | 31.502 | 31.8 | 29.26 | 23.511 | 16.607 | 22.659 |
Gross Profit | 20.308 | 15.126 | 16.895 | 14.288 | 6.173 | 16.529 |
Total Operating Expense | 66.772 | 64.964 | 67.04 | 53.42 | 41.316 | 52.605 |
Selling/General/Admin. Expenses, Total | 27.471 | 26.43 | 29.892 | 25.144 | 21.014 | 26.597 |
Research & Development | 7.799 | 6.229 | 5.203 | 4.765 | 3.695 | 6.048 |
Unusual Expense (Income) | 0 | 0.505 | 2.685 | 0 | 0 | -2.699 |
Operating Income | -14.962 | -18.038 | -20.885 | -15.621 | -18.536 | -13.417 |
Interest Income (Expense), Net Non-Operating | -0.258 | 0.605 | -0.568 | -2.278 | -2.38 | -2.676 |
Net Income Before Taxes | -15.22 | -17.433 | -21.453 | -17.899 | -16.701 | -16.093 |
Net Income After Taxes | -15.371 | 4.249 | -22.116 | -17.855 | -16.829 | -16.158 |
Net Income Before Extra. Items | -15.371 | 4.249 | -22.116 | -17.855 | -16.829 | -16.158 |
Net Income | -15.371 | -16.851 | -21.516 | -17.855 | -16.829 | -16.158 |
Total Adjustments to Net Income | -2.184 | -3.978 | 0 | 0 | -17.378 | -0.546 |
Income Available to Common Excl. Extra. Items | -17.555 | 0.271 | -22.116 | -17.855 | -34.207 | -16.704 |
Income Available to Common Incl. Extra. Items | -17.555 | -20.829 | -21.516 | -17.855 | -34.207 | -16.704 |
Diluted Net Income | -17.555 | -20.829 | -21.516 | -17.855 | -34.207 | -16.704 |
Diluted Weighted Average Shares | 0.48531 | 0.59007 | 0.82352 | 0.92804 | 2.44544 | 5.90984 |
Diluted EPS Excluding Extraordinary Items | -36.1726 | 0.45927 | -26.8554 | -19.2395 | -13.9881 | -2.82647 |
Diluted Normalized EPS | -36.1726 | 1.01555 | -24.7362 | -19.2395 | -13.9881 | -3.12332 |
Total Extraordinary Items | -21.1 | 0.6 | ||||
Other, Net | 4.215 | 0 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 8.116 | 9.134 | 9.531 | 12.408 | 10.166 |
Revenue | 8.116 | 9.134 | 9.531 | 12.408 | 10.166 |
Cost of Revenue, Total | 5.375 | 5.093 | 4.689 | 7.502 | 5.437 |
Gross Profit | 2.741 | 4.041 | 4.842 | 4.906 | 4.729 |
Total Operating Expense | 14.178 | 9.403 | 12.188 | 16.838 | 14.372 |
Selling/General/Admin. Expenses, Total | 7 | 6.09 | 5.93 | 7.669 | 7.391 |
Research & Development | 1.803 | 1.162 | 1.54 | 1.542 | 1.544 |
Operating Income | -6.062 | -0.269 | -2.657 | -4.43 | -4.206 |
Interest Income (Expense), Net Non-Operating | -0.779 | -0.513 | -0.605 | -0.777 | -0.553 |
Net Income Before Taxes | -6.841 | -0.782 | -3.262 | -5.207 | -4.759 |
Net Income After Taxes | -6.901 | -0.702 | -3.276 | -5.279 | -4.776 |
Net Income Before Extra. Items | -6.901 | -0.702 | -3.276 | -5.279 | -4.776 |
Net Income | -6.901 | -0.702 | -3.276 | -5.279 | -4.776 |
Total Adjustments to Net Income | -0.532 | -0.006 | -0.009 | 0 | -0.217 |
Income Available to Common Excl. Extra. Items | -7.433 | -0.708 | -3.285 | -5.279 | -4.993 |
Income Available to Common Incl. Extra. Items | -7.433 | -0.708 | -3.285 | -5.279 | -4.993 |
Diluted Net Income | -7.433 | -0.708 | -3.285 | -5.279 | -4.993 |
Diluted Weighted Average Shares | 5.38344 | 6.0266 | 6.07764 | 6.14228 | 6.159 |
Diluted EPS Excluding Extraordinary Items | -1.38072 | -0.11748 | -0.54051 | -0.85945 | -0.81068 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -1.38072 | -0.43479 | -0.5374 | -0.84622 | -0.81068 |
Unusual Expense (Income) | -2.942 | 0.029 | 0.125 | ||
Other, Net | 0 | 0 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 33.987 | 36.05 | 33.307 | 27.019 | 35.11 | 49.354 |
Cash and Short Term Investments | 8.924 | 11.645 | 8.044 | 5.789 | 17.564 | 29.972 |
Cash & Equivalents | 8.924 | 11.645 | 8.044 | 5.789 | 17.564 | 29.972 |
Total Receivables, Net | 9.784 | 10.124 | 11.112 | 8.76 | 3.059 | 4.238 |
Accounts Receivable - Trade, Net | 9.699 | 10.047 | 10.99 | 8.76 | 3.059 | 4.238 |
Total Inventory | 13.523 | 12.298 | 12.248 | 10.995 | 11.157 | 12.929 |
Prepaid Expenses | 1.505 | 1.732 | 1.591 | 1.163 | 3.018 | 2.012 |
Other Current Assets, Total | 0.251 | 0.251 | 0.312 | 0.312 | 0.312 | 0.203 |
Total Assets | 41.941 | 42.984 | 38.516 | 31.847 | 41.025 | 55.284 |
Property/Plant/Equipment, Total - Net | 4.478 | 3.674 | 1.975 | 1.469 | 2.758 | 2.784 |
Property/Plant/Equipment, Total - Gross | 10.703 | 11.1 | 10.319 | 10.791 | 10.422 | 10.833 |
Accumulated Depreciation, Total | -6.225 | -7.426 | -8.344 | -9.322 | -7.664 | -8.049 |
Goodwill, Net | 2.926 | 2.926 | 2.926 | 2.926 | 2.926 | 2.926 |
Intangibles, Net | 0 | 0 | 0 | 0 | 0 | 0 |
Other Long Term Assets, Total | 0.55 | 0.334 | 0.308 | 0.433 | 0.231 | 0.22 |
Total Current Liabilities | 18.014 | 13.37 | 15.967 | 25.779 | 11.223 | 13.844 |
Accounts Payable | 9.125 | 5.109 | 5.953 | 5.332 | 2.651 | 3.309 |
Accrued Expenses | 4.768 | 4.689 | 6.133 | 3.79 | 5.771 | 6.619 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 13.466 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.159 | 0 | ||||
Other Current Liabilities, Total | 3.962 | 3.572 | 3.881 | 3.191 | 2.801 | 3.916 |
Total Liabilities | 19.876 | 13.724 | 27.427 | 27.505 | 30.997 | 30.076 |
Total Long Term Debt | 0 | 0 | 10.836 | 0 | 16.186 | 13.603 |
Capital Lease Obligations | 0 | |||||
Deferred Income Tax | 0.798 | 0.104 | 0.077 | 0.078 | ||
Other Liabilities, Total | 1.064 | 0.25 | 0.547 | 1.648 | 3.588 | 2.629 |
Total Equity | 22.065 | 29.26 | 11.089 | 4.342 | 10.028 | 25.208 |
Common Stock | 0.068 | 0.102 | 0.021 | 0.031 | 0.098 | 0.154 |
Additional Paid-In Capital | 201.198 | 224.91 | 228.43 | 235.594 | 261.573 | 293.177 |
Retained Earnings (Accumulated Deficit) | -178.325 | -195.176 | -216.692 | -234.547 | -251.376 | -267.534 |
Other Equity, Total | -0.876 | -0.576 | -0.67 | -0.701 | -0.385 | -0.623 |
Total Liabilities & Shareholders’ Equity | 41.941 | 42.984 | 38.516 | 31.847 | 41.025 | 55.284 |
Total Common Shares Outstanding | 0.54053 | 0.81872 | 0.8429 | 1.25756 | 3.90654 | 6.14704 |
Long Term Debt | 10.836 | 0 | 16.186 | 13.603 | ||
Redeemable Preferred Stock | 3.965 | |||||
Total Preferred Shares Outstanding | 0.07 | 0 | 0 | |||
Preferred Stock - Non Redeemable, Net | 0.118 | 0.034 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 57.749 | 55.34 | 52.654 | 49.354 | 43.783 |
Cash and Short Term Investments | 40.842 | 37.081 | 33.385 | 29.972 | 21.606 |
Cash & Equivalents | 40.842 | 37.081 | 33.385 | 29.972 | 21.606 |
Total Receivables, Net | 3.266 | 3.819 | 3.637 | 4.238 | 5.18 |
Accounts Receivable - Trade, Net | 3.266 | 3.819 | 3.637 | 4.238 | 5.18 |
Total Inventory | 11.877 | 12.715 | 14.062 | 12.929 | 14.611 |
Prepaid Expenses | 1.56 | 1.521 | 1.366 | 2.012 | 2.183 |
Other Current Assets, Total | 0.204 | 0.204 | 0.204 | 0.203 | 0.203 |
Total Assets | 63.484 | 61.249 | 58.514 | 55.284 | 50.242 |
Property/Plant/Equipment, Total - Net | 2.583 | 2.758 | 2.712 | 2.784 | 3.302 |
Property/Plant/Equipment, Total - Gross | 10.324 | 10.587 | 10.643 | 10.833 | 11.469 |
Accumulated Depreciation, Total | -7.741 | -7.829 | -7.931 | -8.049 | -8.167 |
Goodwill, Net | 2.926 | 2.926 | 2.926 | 2.926 | 2.926 |
Other Long Term Assets, Total | 0.226 | 0.225 | 0.222 | 0.22 | 0.231 |
Total Current Liabilities | 11.27 | 12.719 | 13.457 | 13.844 | 13.112 |
Accounts Payable | 3.072 | 3.502 | 3.597 | 3.309 | 4.643 |
Accrued Expenses | 5.386 | 5.174 | 4.929 | 6.619 | 5.167 |
Notes Payable/Short Term Debt | 0 | 0.7 | 0 | 0 | 0 |
Other Current Liabilities, Total | 2.812 | 3.343 | 3.531 | 3.916 | 3.302 |
Total Liabilities | 29.968 | 27.993 | 28.192 | 30.076 | 29.642 |
Total Long Term Debt | 16.295 | 12.703 | 12.114 | 13.603 | 13.666 |
Long Term Debt | 16.295 | 12.703 | 12.114 | 13.603 | 13.666 |
Other Liabilities, Total | 2.403 | 2.571 | 2.621 | 2.629 | 2.864 |
Total Equity | 33.516 | 33.256 | 30.322 | 25.208 | 20.6 |
Preferred Stock - Non Redeemable, Net | 0.036 | 0.035 | 0.034 | 0.034 | 0 |
Common Stock | 0.149 | 0.151 | 0.153 | 0.154 | 0.155 |
Additional Paid-In Capital | 292.141 | 292.517 | 292.948 | 293.177 | 293.419 |
Retained Earnings (Accumulated Deficit) | -258.277 | -258.979 | -262.255 | -267.534 | -272.31 |
Other Equity, Total | -0.533 | -0.468 | -0.558 | -0.623 | -0.664 |
Total Liabilities & Shareholders’ Equity | 63.484 | 61.249 | 58.514 | 55.284 | 50.242 |
Total Common Shares Outstanding | 5.97652 | 6.04944 | 6.13108 | 6.14704 | 6.176 |
Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.4 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | -15.371 | -16.851 | -21.516 | -17.855 | -16.829 | -16.158 |
Cash From Operating Activities | -10.596 | -18.412 | -14.147 | -12.746 | -12.795 | -16.71 |
Cash From Operating Activities | 1.048 | 1.203 | 0.945 | 0.982 | 0.499 | 0.4 |
Deferred Taxes | 0.06 | -0.694 | -0.027 | 0.007 | ||
Non-Cash Items | 3.147 | 3.333 | 6.46 | 5.228 | 1.781 | 0.985 |
Cash Taxes Paid | 0.076 | 0.164 | 0.044 | 0.035 | 0.022 | 0.171 |
Cash Interest Paid | 0.004 | 0.001 | 0.023 | 1.784 | 1.881 | 1.771 |
Changes in Working Capital | 0.52 | -5.403 | -0.009 | -1.108 | 1.754 | -1.937 |
Cash From Investing Activities | -1.414 | -0.747 | -0.522 | -0.207 | -0.096 | -0.707 |
Capital Expenditures | -1.414 | -0.747 | -0.558 | -0.207 | -0.096 | -0.707 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0.036 | 0 | ||
Cash From Financing Activities | 9.35 | 21.618 | 11.235 | 10.721 | 24.349 | 29.954 |
Financing Cash Flow Items | 0 | 0 | -1.222 | -0.954 | -3.049 | -1.135 |
Issuance (Retirement) of Stock, Net | 9.521 | 21.764 | 0.003 | 9.175 | 24.958 | 31.114 |
Issuance (Retirement) of Debt, Net | -0.171 | -0.146 | 12.454 | 2.5 | 2.44 | -0.025 |
Foreign Exchange Effects | -0.064 | 0.262 | -0.106 | -0.023 | 0.317 | -0.238 |
Net Change in Cash | -2.724 | 2.721 | -3.54 | -2.255 | 11.775 | 12.299 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -6.901 | -7.603 | -10.879 | -16.158 | -4.776 |
Cash From Operating Activities | -6.499 | -10.008 | -13.606 | -16.71 | -8.021 |
Cash From Operating Activities | 0.085 | 0.176 | 0.281 | 0.4 | 0.117 |
Deferred Taxes | 0 | ||||
Non-Cash Items | 1.118 | -1.461 | -1.035 | 0.985 | 0.42 |
Cash Taxes Paid | 0.01 | 0.13 | 0.154 | 0.171 | 0.026 |
Cash Interest Paid | 0.448 | 0.886 | 1.328 | 1.771 | 0.377 |
Changes in Working Capital | -0.801 | -1.12 | -1.973 | -1.937 | -3.782 |
Cash From Investing Activities | -0.008 | -0.311 | -0.396 | -0.707 | -0.304 |
Capital Expenditures | -0.008 | -0.311 | -0.396 | -0.707 | -0.304 |
Cash From Financing Activities | 29.825 | 29.811 | 29.886 | 29.954 | 0 |
Financing Cash Flow Items | -0.006 | -0.006 | -0.006 | -1.135 | 0 |
Issuance (Retirement) of Stock, Net | 29.831 | 29.841 | 29.917 | 31.114 | 0 |
Foreign Exchange Effects | -0.148 | -0.083 | -0.171 | -0.238 | -0.041 |
Net Change in Cash | 23.17 | 19.409 | 15.713 | 12.299 | -8.366 |
Issuance (Retirement) of Debt, Net | -0.024 | -0.025 | -0.025 |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group 500000+
Trader
92000+
Klien aktif per bulan
$53000000+
Volume investasi per bulan
$30000000+
Coba sekarang Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Advanced Medical Equipment & Technology (NEC) |
27042 Towne Centre Drive
Suite 270
FOOTHILL RANCH
CALIFORNIA 92610
US
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com